KKR to Present at the Bernstein Strategic Decisions Conference 2021
Get Alerts KKR Hot Sheet
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- KKR & Co. Inc. (NYSE: KKR) announced today that Scott C. Nuttall, Co-President and Co-Chief Operating Officer, will present at the Bernstein Strategic Decisions Conference 2021 on Wednesday, June 2, 2021 at 3:30 PM ET.
A live webcast of the presentation will be available on the Investor Center section of KKR’s website at https://ir.kkr.com/events-presentations/. For those unable to listen to the live webcast, a replay will be available on the website shortly after the event.
Any questions regarding the webcast may be addressed to KKR’s Investor Relations group at [email protected].
ABOUT KKR
KKR is a leading global investment firm that offers alternative asset management and capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of The Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at www.kkr.com and on Twitter @KKR_Co.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005691/en/
Investor Relations:
Craig Larson
+1 (877) 610-4910 (U.S.) / +1 (212) 230-9410
[email protected]
Media:
Cara Major or Miles Radcliffe-Trenner
+ 1 (212) 750-8300
[email protected]
Source: KKR & Co. Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resect
- Spire Global Delivers 10 Satellites to Vandenberg Space Force Base Ahead of the Transporter-17 Rideshare Mission
- CANADIAN SPACE AGENCY AND MDA SPACE CONCLUDE CONTRACT FOR REPLENISHMENT SATELLITE VALUED AT $688M
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Sanford C. Bernstein, Twitter, Hedge FundsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share